A nonimmunosuppressant approach on Asia psoriasis subjects: 5-year followup and 11-year data analysis.
Dermatology research and practice • Vol. 2012 • 2012
[Future perspectives in the treatment of psoriasis: news in biological therapies].
Acta medica portuguesa • Vol. 24, Issue 6 • 2011
A supratherapeutic dose of the Janus kinase inhibitor tasocitinib (CP-690,550) does not prolong QTc interval in healthy participants.
Journal of clinical pharmacology • Vol. 51, Issue 9 • 2011
Potential of emerging immunosuppressive strategies to improve the posttransplant cardiovascular risk profile.
Kidney international. Supplement, Issue 118 • 2010
